drugset

drugset / Trial / NCT01113593

A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease

NCT01113593 ↗

Phase 2 Completed 45 enrolled Dey

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to characterize the pharmacodynamic profile of Formoterol Fumarate and Foradil Aerolizer

Timeline

Start: 2010-05
Primary completion: 2010-05
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Formoterol	Other / unclassified	—	Inhaled

Indications